Vitamins K2 and D3 Improve Long COVID, Fungal Translocation, and Inflammation: Randomized Controlled Trial.

Publication date: Jan 16, 2025

Long COVID (LC) is characterized by persistent symptoms at least 3 months after a SARS-COV-2 infection. LC has been associated with fungal translocation, gut dysfunction, and enhanced systemic inflammation. Currently, there is no approved treatment for this condition. The anti-inflammatory effect of vitamins K2 and D3 was shown to help attenuate the course of acute COVID-19 infection. This trial aims to investigate the effects of vitamins K2/D3 on LC symptoms, as well as gut and inflammatory markers, in people with established long COVID. Our hypothesis is that by attenuating systemic inflammation, vitamins K2/D3 will improve long COVID symptoms. This single-site randomized controlled study enrolled adults experiencing ≥2 moderate LC symptoms at least 3 months after a COVID-19 infection. The RECOVER Long COVID Research Index and number and type of LC symptoms were considered. Participants were randomized 2:1 to daily 240 ug K2 (pure MK-7 form) and 2000 UI vitamin D3 or standard of care (SOC) for 24 weeks. The endpoints were changes in symptomatology and in select inflammatory, metabolic, and gut biomarkers at 24 weeks. We enrolled 151 participants (n = 98 received vit K2/D3 and 53 received SOC). The median age was 46 years; 71% were female and 29% were non-white. Baseline demographics were balanced between groups. At 24 weeks, the active treatment group only had a sharp increase in 25(OH) D, indicating good treatment adherence. In the vitamin K2/D3 arm, there was a 7. 1% decrease in the proportion who had an LC Index ≥12 (vs. a 7. 2% increase in the SOC group; p = 0. 01). The average number of LC symptoms remained stable in the vitamin K2/D3 arm but increased in the SOC arm (p = 0. 03). Additionally, reductions in oxidized LDL, inflammatory markers sTNF-RI and sCD163, and fungal translocation marker (1,3)-β-d-glucan were observed in the vitamin K2/D3 arm compared to the SOC arm (p < 0. 01) over 24 weeks. Vitamins K2/D3 improved the RECOVER Long COVID Index, the number of LC symptoms, and several gut and inflammatory markers. Vitamins K2/D3 provide a promising safe intervention for people suffering from long COVID.

Open Access PDF

Concepts Keywords
Adults Adult
Biomarkers Aged
Fungal Biomarkers
Months Biomarkers
Vitamins Cholecalciferol
Cholecalciferol
chronic inflammation
COVID-19
COVID-19 Drug Treatment
Female
fungal translocation
Fungi
gut permeability
Humans
Inflammation
long COVID
Male
Middle Aged
Post-Acute COVID-19 Syndrome
SARS-CoV-2
Vitamin K 2
Vitamin K 2
Vitamins
Vitamins

Semantics

Type Source Name
pathway REACTOME Vitamins
disease MESH Long COVID
disease MESH Inflammation
disease MESH SARS-COV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH infection
disease IDO site
drug DRUGBANK Cholecalciferol
disease IDO intervention
disease IDO entity
disease IDO acute infection
disease MESH brain fog
disease MESH atherosclerosis
disease MESH respiratory diseases
disease IDO production
pathway REACTOME Antimicrobial peptides
disease MESH vitamin deficiencies
drug DRUGBANK Vitamin D
disease MESH death
disease IDO nucleic acid
disease MESH allergies
drug DRUGBANK Ranitidine
disease MESH substance use
disease IDO blood
disease IDO symptom
drug DRUGBANK Dextrose unspecified form
disease MESH insulin resistance
pathway KEGG Insulin resistance
disease IDO assay

Original Article

(Visited 2 times, 1 visits today)